CABIO(SH:688089) Xin Lang Cai Jing·2026-01-08 11:53Core Viewpoint - Nestlé has initiated a precautionary recall of infant formula in 45 countries due to quality issues with raw materials from a supplier, although no adverse health reports have been received so far [1][4]. Group 1: Company Actions - Nestlé announced the recall of affected infant formula products in China, the UK, Germany, and other countries, emphasizing that its registered special medical infant formula products in China are not affected [1][4]. - The supplier of the problematic Arachidonic Acid (ARA) raw material has not been officially identified, but speculation points to a biotechnology company in Wuhan, Jia Bi You [1][4]. - Jia Bi You's stock fell over 13% following the news, closing down 11.91% at 21.15 yuan on January 8 [3]. Group 2: Industry Impact - ARA is a crucial component for infant brain and nervous system development, making it a key ingredient in infant formula [4]. - The quality issue involves a toxin from Bacillus cereus, which can cause gastrointestinal problems, although such occurrences are rare [4]. - Several dairy companies, including Danone and FrieslandCampina, have publicly stated that they do not use ARA from the implicated supplier, reinforcing their product safety [9][10]. Group 3: Supplier Dynamics - Jia Bi You is the largest ARA supplier in China and a significant player internationally, with established relationships with major infant formula brands [5][11]. - The company’s ARA business generated 390 million yuan, accounting for 70.27% of its total revenue, highlighting its reliance on this segment [11]. - The incident may negatively impact Jia Bi You's competitiveness and future market expansion, as other companies may have alternative ARA suppliers [11].